<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/109785">
      <dc:title>Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series</dc:title>
      <dc:creator>Urias-Barreras, Cynthia M.</dc:creator>
      <dc:creator>Rodríguez Archilla, Alberto</dc:creator>
      <dc:creator>Canizalez-Roman, Adrian</dc:creator>
      <dc:creator>Bastidas, Daniela A.</dc:creator>
      <dc:creator>León-Sicairos, Nidia M.</dc:creator>
      <dc:subject>Aspergillosis</dc:subject>
      <dc:subject>COVID-19</dc:subject>
      <dc:subject>Invasive fungal infections</dc:subject>
      <dc:description>Background: Fungal infections, during or as a consequence of SARS-CoV-2 infection, associated with uncontrolled diabetes mellitus and indiscriminate use of corticosteroids have been reported. In the jaw, mostly mucormycosis has been diagnosed in hospitals.&#xd;
Methods: A retrospective, cross-sectional, descriptive study of the clinical, imaging, and histopathologic characteristics of maxillary invasive fungal infection in post-COVID-19 patients diagnosed in a private non-hospital oral pathology service in Mexico during 2020-2022 was conducted.&#xd;
Results: We found 20 cases of maxillary invasive fungal infections in post-COVID-19 patients, 75% including a diagnosis of mucormycosis and 25% diagnosed as probable aspergillosis. The most common signs and symptoms were exposed necrotic bone followed by tooth mobility, discharge, and pain. On imaging, unilateral maxillary sinus involvement was observed in 6 cases (30%), and bilateral maxillary sinus involvement was observed in 3 cases (15%).&#xd;
Conclusions: It is essential to consider the association of osteonecrosis of the jaw in post-COVID-19 patients, with aspergillosis, not only mucormycosis, for early diagnosis and appropriate treatment.</dc:description>
      <dc:date>2026-01-16T09:20:34Z</dc:date>
      <dc:date>2026-01-16T09:20:34Z</dc:date>
      <dc:date>2024-02</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Publisher version: Urias-Barreras, C. M.; Rodríguez Archilla, A.; Canizalez-Roman, A. [et al.]. (2024). Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series. Journal of Stomatology, Oral and Maxillofacial Surgery Volume 125, Issue 1, February 2024, 101615. https://doi.org/10.1016/j.jormas.2023.101615</dc:identifier>
      <dc:identifier>2468-7855</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/109785</dc:identifier>
      <dc:identifier>10.1016/j.jormas.2023.101615</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
      <dc:publisher>Elsevier</dc:publisher>
   </ow:Publication>
</rdf:RDF>